Saudi Pharmaceutical Journal (Jan 2021)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)

  • Mandlin Abdulaziz Almousa,
  • Ghadah Khalid Alharbi,
  • Amerah Saeed Alqahtani,
  • Yusra Chachar,
  • Lubna Alkadi,
  • Ali Aboalela

Journal volume & issue
Vol. 29, no. 1
pp. 96 – 103

Abstract

Read online

Background: Medication-related osteonecrosis of the jaw (MRONJ) is a complication affecting patients who are being treated with antiresorptive or antiangiogenic medication. These patients require meticulous treatment planning and management strategies. This research aimed to assess the knowledge of dental practitioners and students in their professional years regarding MRONJ. Methods: A cross-sectional study was conducted among 345 dental practitioners and students in their professional years of both genders, in governmental and private dental schools. The data was collected using an electronic and paper-based self-administered structured questionnaire with six sections. The data was entered and analyzed using SPSS Version 23, and a P-value <0.05 was considered significant. A Chi-square test was used to compare the categorical variables. Results: Though more than half of the sample 68% received information about antiresorptive and antiangiogenic drugs during their studies, the level of knowledge was low. The primary diseases targeted by antiresorptive and antiangiogenic medications were not known by the majority of the sample. Almost half of the sample could not identify any antiresorptive or antiangiogenic medication and only 28.1% knew the correct definition of MRONJ. Conclusion: The level of knowledge regarding MRONJ is a concern, necessitating more educational courses and workshops.

Keywords